[DOI] [PMC free article] [PubMed] [Google Scholar] 17.van der Put N.M., Gabrels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., Blom H.J
Solution to Review Problem 6.4 Base Case: Laser sales price increases 10 percent: Total profit would increase $240,000 (from loss of $100,000 in base case to profit of $140,000 in this scenario)
Regulators including the FDA and MHRA have mechanisms for expedited review of breakthrough therapies
Your provider agrees the trajectory meets your goals

Disclosure of interest: Laurine Bedoucha : nothing to disclose Claire Gobron : nothing to disclose Fabrice Vallee : nothing to disclose Etienne Gayat : nothing to disclose Peggy Reiner : nothing to disclose Candice Sabben : nothing to disclose Michael Obadia : nothing to disclose Perrine Boursin : nothing to disclose Estelle Dubus : nothing to disclose Eric Jouvent : nothing to disclose Mikael Mazighi : nothing to disclose Lucas Di Meglio : nothing to disclose Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P037 - ESOC25-504 CLINICAL AND ORGANISATIONAL PRACTICES IN THE ACUTE PHASE OF ISCHAEMIC STROKE IN QUEBEC BY SEX AND AGE: RESULTS OF A DESCRIPTIVE STUDY Amlie Blanger 1 , Julie Houle 1 , Line Beaudet 2 1 Universit du Qubec Trois-Rivires, Trois-Rivires, Canada, 2 Centre de recherche du Centre hospitalier de l'Universit de Montral (CRCHUM), Montral, Canada Background and Aims: The quality of interdisciplinary care during the acute phase of ischaemic stroke remains underexplored in Canada, particularly in Quebec

in the second half of this year